Antibody drug conjugates against the receptor for advanced glycation end products (RAGE), a novel therapeutic target in endometrial cancer.
- DOI
- 10.1186/s40425-019-0765-z
- Published
- 2019 Oct 29
- Container
- Journal for immunotherapy of cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s40425-019-0765-z,
title = {Antibody drug conjugates against the receptor for advanced glycation end products (RAGE), a novel therapeutic target in endometrial cancer.},
author = {Healey GD and Pan-Castillo B and Garcia-Parra J and Davies J and Roberts S and Jones E and Dhar K and Nandanan S and Tofazzal N and Piggott L and Clarkson R and Seaton G and Frostell A and Fagge T and McKee C and Margarit L and Conlan RS and Gonzalez D},
year = {2019},
journal = {Journal for immunotherapy of cancer},
doi = {10.1186/s40425-019-0765-z},
url = {https://doi.org/10.1186/s40425-019-0765-z}
}RIS
TY - JOUR TI - Antibody drug conjugates against the receptor for advanced glycation end products (RAGE), a novel therapeutic target in endometrial cancer. AU - Healey GD AU - Pan-Castillo B AU - Garcia-Parra J AU - Davies J AU - Roberts S AU - Jones E AU - Dhar K AU - Nandanan S AU - Tofazzal N AU - Piggott L AU - Clarkson R AU - Seaton G AU - Frostell A AU - Fagge T AU - McKee C AU - Margarit L AU - Conlan RS AU - Gonzalez D PY - 2019 JO - Journal for immunotherapy of cancer DO - 10.1186/s40425-019-0765-z UR - https://doi.org/10.1186/s40425-019-0765-z ER -
APA
GD, H., B, P., J, G., J, D., S, R., E, J., K, D., S, N., N, T., L, P., R, C., G, S., A, F., T, F., C, M., L, M., RS, C., & D, G. (2019). Antibody drug conjugates against the receptor for advanced glycation end products (RAGE), a novel therapeutic target in endometrial cancer.. Journal for immunotherapy of cancer. https://doi.org/10.1186/s40425-019-0765-z
Source records
- pubmed · retrieved 2026-09-26T02:10:58.005Z